Literature DB >> 10450930

Thermodynamic in vitro studies as a method to investigate the pharmacodynamic behavior of adenosine A1 receptor ligands.

A Dalpiaz1, A Scatturin, B Pavan, K Varani, A P IJzerman, P Andrea Borea.   

Abstract

PURPOSE: A thermodynamic analysis of the binding to rat cortex adenosine A1 receptor of N6-substituted (full agonists) and N6-substituted-deoxyribose (partial agonists) adenosine derivatives was performed. The intrinsic activity of the compounds was evaluated by measurements of the inhibition of forskolin stimulated 3', 5'-cyclic adenosine monophosphate (c-AMP) levels in isolated epididymal rat adipocytes.
METHODS: The thermodynamic parameters deltaG(o) (standard free energy), deltaH(o) (standard enthalpy), and deltaS(o) (standard entropy) of the binding equilibrium were determined by means of affinity measurements carried out at different temperatures (0, 10, 20, 25, 30 degrees C). Levels of c-AMP were evaluated performing competitive protein binding assays.
RESULTS: The binding of the ligands increases with temperature enhancement and, as a consequence, is totally entropy driven. Standard entropy values correlate significantly with intrinsic activity ones.
CONCLUSIONS: It is proposed the data obtained by these in vitro experiments can be used to investigate the in vivo pharmacodynamic of A, full and partial agonists.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10450930     DOI: 10.1023/a:1018987816891

Source DB:  PubMed          Journal:  Pharm Res        ISSN: 0724-8741            Impact factor:   4.200


  22 in total

1.  Adenosine regulates via two different types of receptors, the accumulation of cyclic AMP in cultured brain cells.

Authors:  D van Calker; M Müller; B Hamprecht
Journal:  J Neurochem       Date:  1979-11       Impact factor: 5.372

Review 2.  A systems approach to molecular structure, intermolecular recognition, and emergence-dissolvence in medicinal research.

Authors:  B Testa; L B Kier; P A Carrupt
Journal:  Med Res Rev       Date:  1997-07       Impact factor: 12.944

3.  Inverse agonism: pharmacological curiosity or potential therapeutic strategy?

Authors:  G Milligan; R A Bond; M Lee
Journal:  Trends Pharmacol Sci       Date:  1995-01       Impact factor: 14.819

Review 4.  Cardiac electrophysiology and pharmacology of adenosine: basic and clinical aspects.

Authors:  A Pelleg; L Belardinelli
Journal:  Cardiovasc Res       Date:  1993-01       Impact factor: 10.787

5.  A modification of a protein-binding method for rapid quantification of cAMP in cell-culture supernatants and body fluid.

Authors:  C Nordstedt; B B Fredholm
Journal:  Anal Biochem       Date:  1990-09       Impact factor: 3.365

Review 6.  Analysis of drug-receptor interactions in vivo: a new approach in pharmacokinetic-pharmacodynamic modelling.

Authors:  P H Van der Graaf; M Danhof
Journal:  Int J Clin Pharmacol Ther       Date:  1997-10       Impact factor: 1.366

7.  Biochemical and pharmacological characterization of periodate-oxidized adenosine analogues at adenosine A1 receptors.

Authors:  A Dalpiaz; K Varani; P A Borea; C Martini; G Chiellini; A Lucacchini
Journal:  Biochim Biophys Acta       Date:  1995-06-20

8.  Essential role of adenosine, adenosine A1 receptors, and ATP-sensitive K+ channels in cerebral ischemic preconditioning.

Authors:  C Heurteaux; I Lauritzen; C Widmann; M Lazdunski
Journal:  Proc Natl Acad Sci U S A       Date:  1995-05-09       Impact factor: 11.205

9.  Two affinity states of Ri adenosine receptors in brain membranes. Analysis of guanine nucleotide and temperature effects on radioligand binding.

Authors:  M J Lohse; V Lenschow; U Schwabe
Journal:  Mol Pharmacol       Date:  1984-07       Impact factor: 4.436

Review 10.  Adenosine A1 and A2 receptors: structure--function relationships.

Authors:  P J van Galen; G L Stiles; G Michaels; K A Jacobson
Journal:  Med Res Rev       Date:  1992-09       Impact factor: 12.944

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.